Can prodromal symptoms predict recurrence of vasovagal syncope?

Cardiology Journal

Volumn 15, Issue 5, 2008, Pages 446-450

  Fazelifar, Amir Farjam ^a   Basiri, Hosein Ali ^a   Tolooie, Ali ^a   Haghjoo, Majid ^a   Barakpour, Hamid ^a   Emkanjoo, Zahra ^a   Abkenar, Hooman Bakhshandeh ^a   Zeighami, Mahboubeh ^a   Asgari, Foroozan ^a   Sadr Ameli, Mohammad Ali ^a  

^a IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Beta Mocker therapy; Prodromal symptoms; Vasovagal syncope

Indexed keywords

METOPROLOL;

ADULT; AGED; ANAMNESIS; ARTICLE; BLURRED VISION; DIAPHORESIS; DRUG MEGADOSE; FEMALE; FOLLOW UP; HEAD TILTING; HEART PALPITATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MAXIMUM TOLERATED DOSE; NAUSEA; PREDICTOR VARIABLE; RECURRENCE RISK; RECURRENT DISEASE; SYMPTOM; SYNCOPE; TILT TABLE TEST;

ADOLESCENT; ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; HEART RATE; HUMANS; MALE; MIDDLE AGED; NAUSEA; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RECURRENCE; SWEATING; SYNCOPE, VASOVAGAL; TILT-TABLE TEST; VISION DISORDERS; YOUNG ADULT;

EID: 54849434020     PISSN: 18975593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Mosqueda-Garcia R, Furlan F, Tank J, Fernandez-Violante R. The elusive pathophysiology of neurally mediated syncope. Circulation, 2000; 102: 2898-2906.
2. Benditt DG, Fahy GJ, Lurie KG, Sakaguchi S, Fabian W, Samniah N. Pharmacotherapy of neurally mediated syncope. Circulation, 1999; 100: 1242-1248.
3. Madrid AH, Ortega J, Rebollo JG et al. Lack of efficacy of atenolol for the prevention of neurally mediated syncope in a high symptomatic population: A prospective, double-blind, randomized and placebo-controlled study. J Am Coll Cardiol, 2001; 37: 554-559.
4. Gajek J, Zysko D, Mazurek W. Efficacy of tilt training in patients with vasovagal syncope. Kardiol Pol, 2006; 64: 602-608.
5. Verheyden B, Ector H, Aubert AE, Reybrouck T. Tilt training increases the vasoconstrictor reserve in patients with neurally mediated syncope evoked by head-up tilt testing. Eur Heart J, 2008; 29: 1523-1530.
6. Chosy JJ, Graham DT. Catecholamines in vasovagal fainting. J Psychosom Res, 1965; 9: 189-194.
7. Benditt DG, Ermis C, Padanilam B, Samniah N, Sakaguchi S. Catecholamine response during haemodynamically stable upright posture in individuals with and without tilt-table induced vasovagal syncope. Europace, 2003; 5: 65-70.
8. Yamanouchi Y, Shehadeh AA, Fouad-Tarazi FM. Usefulness of plasma catecholamines during head-up tilt as a measure of sympathetic activation in vasovagal patients. Pacing Clin Electrophysiol, 1998; 21: 1539-1545.
9. Mitro P, Rybárová E, Zemberová E, Tkác I. Enhanced plasma catecholamine and cAMP response during the head-up tilt test in patients with vasovagal syncope. Wien Klin Wochenschr, 2005; 117: 353-358.
10. Asso A, Milstein S, Dunnigan A, Remole S, Benditt DG. Prognostic significance of parenteral metoprolol during head-up tilt testing. Circulation, 1991; 84 (suppl. II): II409 (abstract).
11. Muller G, Deal BJ, Strasburger JF, Woodrow Benson D. Usefulness of metoprolol for unexplained syncope and positive response to tilt testing in young persons. Am J Cardiol, 1993; 71: 592-595.
12. Nair N, Padder FA, Kutalek SP, Kantharia BK. Usefulness of pindolol for treatment of neurocardiogenic syncope. Am J Cardiol, 2004; 94: 1189-1191.
13. Sheldon R, Connolly S, Rose S et al.; for the POST Investigators. Prevention of Syncope Trial (POST). A randomized, placebo-controlled study of metoprolol in the prevention of vasovagal syncope. Circulation, 2006; 113: 1164-1170.
14. Alegria JR, Gersh BJ, Scott ChG, Hodge DO, Hammill SC, Shen W-K. Comparison of frequency of recurrent syncope after beta-blocker therapy versus conservative management for patients with vasovagal syncope. Am J Cardiol, 2003; 92: 82-84.
15. Fenton AM, Hammill SC, Rea RF, Low PA, Shen W-K. Vasovagal syncope. Ann Intern Med, 2000; 133: 714-725.
16. Sheldon R, Rose S, Flanagan P, Lou Koshman M, Killam S. Risk factors for syncope recurrence after a positive tilt-table test in patients with syncope. Circulation, 1996; 93: 973-981.